| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
Gene transferAdenovirusAtadenovirusBAC YAC artificial chromosomeDNA VaccineXenobioticsOxygen (Hypoxia)Redox (BASKET)Radiation therapyNeoplasia (Tumor biology and immunology)Ultrasound (Toxicity and therapeutic use)RNA (MicroRNA)MorpholinoExon skippingTransposonRegeneration of tissues and other biologic structuresRPE65Biomembranes (BASKET)SplicingLaboratory animal (Pig)Synthetic biologyNanomedicine| 1 | 1999 | Herpes simplex virus vectors for gene therapy in Parkinson's disease and other diseases of the nervous system. | 
| + | - | nl | J R Soc Med 92(11):566-70 (1999) |
| 2 | 1997 | Optimal techniques for arterial gene transfer. | 
| + | - | nl | Cardiovasc Res 35(3):391-404 (1997) |
| 3 | 2006 | Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. | 
| + | - | nl | Pharmacol Rev 58(1):32-45 (2006) |
| 4 | 2000 | Design of retroviral vectors and helper cells for gene therapy. | 
| + | - | nl | Pharmacol Rev 52(4):493-511 (2000) |
| 5 | 2005 | Baculovirus as a highly efficient expression vector in insect and mammalian cells. | 
| + | - | nl | Acta Pharmacol Sin 26(4):405-16 (2005) |
| 6 | 2009 | Herpes vector-mediated gene transfer in the treatment of chronic pain. | 
| + | - | nl | Mol Ther 17(1):13-8 (2009) |
| 7 | 2008 | Recombinant adeno-associated virus transduction and integration. | 
| + | - | nl | Mol Ther 16(7):1189-99 (2008) |
| 8 | 2008 | Gene delivery to the nervous system. | 
| + | - | nl | Mol Ther 16(4):640-6 (2008) |
| 9 | 2007 | Advances in preclinical investigation of prostate cancer gene therapy. | 
| + | - | nl | Mol Ther 15(6):1053-64 (2007) |
| 10 | 2009 | DNA as therapeutics; an update. | 
| + | - | nl | Indian J Pharm Sci 71(5):488-98 (2009) |
| 11 | 2008 | Nano-vectors for efficient liver specific gene transfer. | 
| + | - | nl | Int J Nanomedicine 3(1):31-49 (2008) |
| 12 | 2007 | Virus-mediated gene transfer to induce therapeutic angiogenesis: where do we stand? | 
| + | - | nl | Int J Nanomedicine 2(4):527-40 (2007) |
| 13 | 2007 | Layered double hydroxide nanoparticles as cellular delivery vectors of supercoiled plasmid DNA. | 
| + | - | nl | Int J Nanomedicine 2(2):163-74 (2007) |
| 14 | 2000 | Update on adenovirus and its vectors. | 
| + | - | nl | J Gen Virol 81(Pt 11):2573-604 (2000) |
| 15 | 1983 | Cloning vectors derived from animal viruses. | 
| + | - | nl | J Gen Virol 64 (Pt 2)(-):255-66 (1983) |
| 16 | 2010 | Herpesvirus vectors for therapy of brain tumors. | 
| + | - | nl | Open Virol J 4(-):103-8 (2010) |
| 17 | 2004 | Ovine atadenovirus: a review of its biology, biosafety profile and application as a gene delivery vector. | 
| + | - | nl | Immunol Cell Biol 82(2):189-95 (2004) |
| 18 | 2007 | Potential of helper-dependent adenoviral vectors in modulating airway innate immunity. | 
| + | - | nl | Cell Mol Immunol 4(2):81-9 (2007) |
| 19 | 2007 | BAC to immunology--bacterial artificial chromosome-mediated transgenesis for targeting of immune cells. | 
| + | - | nl | Immunology 121(3):308-13 (2007) |
| 20 | 2009 | Use of HIV as a gene transfer vector. | 
| + | - | nl | Acta Biochim Pol 56(4):531-95 (2009) |
| 21 | 2005 | Adeno-associated virus vector-mediated gene delivery to the vasculature and kidney. | 
| + | - | nl | Acta Biochim Pol 52(2):293-9 (2005) |
| 22 | 2004 | Production of functional transgenic mice by DNA pronuclear microinjection. | 
| + | - | nl | Acta Biochim Pol 51(1):9-31 (2004) |
| 23 | 2006 | Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors. | 
| + | - | nl | Cell Res 16(3):241-59 (2006) |
| 24 | 2000 | Gene transfer into chicken embryos by retrovirus vectors. | 
| + | - | nl | Dev Growth Differ 42(3):213-8 (2000) |
| 25 | 2000 | Application of efficient and specific gene transfer systems and organ culture techniques for the elucidation of mechanisms of epithelial-mesenchymal interaction in the developing gut. | 
| + | - | nl | Dev Growth Differ 42(3):207-11 (2000) |
| 26 | 2009 | Progress and prospects: the design and production of plasmid vectors. | 
| + | - | nl | Gene Ther 16(2):165-71 (2009) |
| 27 | 2008 | Manufacturing and characterizing AAV-based vectors for use in clinical studies. | 
| + | - | nl | Gene Ther 15(11):840-8 (2008) |
| 28 | 2008 | AAV-mediated gene therapy for retinal disorders: from mouse to man. | 
| + | - | nl | Gene Ther 15(11):849-57 (2008) |
| 29 | 2008 | Clinical gene therapy using recombinant adeno-associated virus vectors. | 
| + | - | nl | Gene Ther 15(11):858-63 (2008) |
| 30 | 2008 | AAV vectors for RNA-based modulation of gene expression. | 
| + | - | nl | Gene Ther 15(11):864-9 (2008) |
| 31 | 2008 | Toward exascale production of recombinant adeno-associated virus for gene transfer applications. | 
| + | - | nl | Gene Ther 15(11):823-30 (2008) |
| 32 | 2008 | Potential of AAV vectors in the treatment of metabolic disease. | 
| + | - | nl | Gene Ther 15(11):831-9 (2008) |
| 33 | 2008 | Adeno-associated virus integration: virus versus vector. | 
| + | - | nl | Gene Ther 15(11):817-22 (2008) |
| 34 | 2008 | Strategies for manufacturing recombinant adeno-associated virus vectors for gene therapy applications exploiting baculovirus technology. | 
| + | - | nl | Brief Funct Genomic Proteomic 7(4):303-11 (2008) |
| 35 | 2007 | Animal transgenesis: state of the art and applications. | 
| + | - | nl | J Appl Genet 48(1):47-61 (2007) |
| 36 | 2007 | Transformation of plasmid DNA into E. coli using the heat shock method. | 
| + | - | nl | J Vis Exp -(6):253 (2007) |
| 37 | 2006 | Gene-gun transfection of hippocampal neurons. | 
| + | - | nl | J Vis Exp -(1):121 (2006) |
| 38 | 1999 | HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications. | 
| + | - | nl | Neoplasia 1(5):402-16 (1999) |
| 39 | 1999 | HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis. | 
| + | - | nl | Neoplasia 1(5):387-401 (1999) |
| 40 | 2009 | Murine bone marrow-derived mesenchymal stem cells as vehicles for interleukin-12 gene delivery into Ewing sarcoma tumors. | 
| + | - | nl | Cancer 115(1):13-22 (2009) |
| 41 | 2002 | Adenoviral gene therapy. | 
| + | - | nl | Oncologist 7(1):46-59 (2002) |
| 42 | 2008 | Clinical relevance of the homologous recombination machinery in cancer therapy. | 
| + | - | nl | Cancer Sci 99(2):187-94 (2008) |
| 43 | 2006 | Non-viral vectors for cancer therapy. | 
| + | - | nl | Cancer Sci 97(5):348-54 (2006) |
| 44 | 2001 | Adeno-associated virus for cancer gene therapy. | 
| + | - | nl | Cancer Res 61(17):6313-21 (2001) |
| 45 | 2005 | Vector-mediated cancer gene therapy: an overview. | 
| + | - | nl | Cancer Biol Ther 4(5):512-7 (2005) |
| 46 | 2009 | The 'timely' development of Rexin-G: first targeted injectable gene vector (review). | 
| + | - | nl | Int J Oncol 35(2):229-38 (2009) |
| 47 | 2006 | Pathotropic nanoparticles for cancer gene therapy Rexin-G IV: three-year clinical experience. | 
| + | - | nl | Int J Oncol 29(5):1053-64 (2006) |
| 48 | 2009 | Armed replicating adenoviruses for cancer virotherapy. | 
| + | - | nl | Cancer Gene Ther 16(6):473-88 (2009) |
| 49 | 2006 | Transductional targeting of adenovirus vectors for gene therapy. | 
| + | - | nl | Cancer Gene Ther 13(9):830-44 (2006) |
| 50 | 2005 | Adeno-associated virus vectors: potential applications for cancer gene therapy. | 
| + | - | nl | Cancer Gene Ther 12(12):913-25 (2005) |
| 51 | 2002 | Adenoviral vectors: systemic delivery and tumor targeting. | 
| + | - | nl | Cancer Gene Ther 9(12):1036-42 (2002) |
| 52 | 2002 | Selectively replicating viral vectors. | 
| + | - | nl | Cancer Gene Ther 9(12):987-1000 (2002) |
| 53 | 2002 | Intravascular adenoviral agents in cancer patients: lessons from clinical trials. | 
| + | - | nl | Cancer Gene Ther 9(12):979-86 (2002) |
| 54 | 2002 | RNA viruses as virotherapy agents. | 
| + | - | nl | Cancer Gene Ther 9(12):961-6 (2002) |
| 55 | 2002 | Virotherapy for cancer: current status, hurdles, and future directions. | 
| + | - | nl | Cancer Gene Ther 9(12):959-60 (2002) |
| 56 | 2002 | Viruses as gene delivery vectors: application to gene function, target validation, and assay development. | 
| + | - | nl | Cancer Gene Ther 9(8):692-9 (2002) |
| 57 | 2000 | Adenovirus as a gene therapy vector for hematopoietic cells. | 
| + | - | nl | Cancer Gene Ther 7(6):816-25 (2000) |
| 58 | 1999 | Development and application of adenoviral vectors for gene therapy of cancer. | 
| + | - | nl | Cancer Gene Ther 6(2):113-38 (1999) |
| 59 | 1996 | Keratinocyte gene transfer and gene therapy. | 
| + | - | nl | Crit Rev Oral Biol Med 7(3):204-21 (1996) |
| 60 | 2008 | Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. | 
| + | - | nl | Nucleic Acids Res 36(12):4158-71 (2008) |
| 61 | 2000 | Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications. | 
| + | - | nl | Stem Cells 18(1):19-39 (2000) |
| 62 | 1997 | Gene transfer into hematopoietic cells. | 
| + | - | nl | Stem Cells 15 Suppl 1(-):123-34 (1997) |
| 63 | 2005 | Nonviral gene transfer to skeletal, smooth, and cardiac muscle in living animals. | 
| + | - | nl | Am J Physiol Cell Physiol 289(2):C233-45 (2005) |
| 64 | 2007 | The problem of passenger genes in transgenic mice. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 27(10):2100-3 (2007) |
| 65 | 1999 | Vascular gene transfer : from bench to bedside. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 19(2):196-207 (1999) |
| 66 | 1999 | Gene therapy for rheumatic diseases. | 
| + | - | nl | Arthritis Rheum 42(1):1-16 (1999) Evans CH |
| 67 | 2008 | Development of gene therapy for blood disorders. | 
| + | - | nl | Blood 111(9):4431-44 (2008) |
| 68 | 1999 | Gene transfer by adenovectors. | 
| + | - | nl | Blood 94(12):3965-7 (1999) |
| 69 | 1997 | Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders. | 
| + | - | nl | Brain 120 ( Pt 7)(-):1245-59 (1997) |
| 70 | 1997 | Adenoviral vectors for hepatic gene transfer in animals. | 
| + | - | nl | Chest 111(6 Suppl):138S-142S (1997) |
| 71 | 2008 | Gene therapy in heart failure. | 
| + | - | nl | Circ Res 102(12):1458-70 (2008) |
| 72 | 2006 | Induction of HIF-1alpha and iNOS with siRNA: a novel mechanism for myocardial protection. | 
| + | - | nl | Circ Res 98(1):10-1 (2006) Lefer DJ |
| 73 | 2001 | Assessment of risks associated with cardiovascular gene therapy in human subjects. | 
| + | - | nl | Circ Res 89(5):389-400 (2001) |
| 74 | 2007 | Therapeutic gene regulation: targeting transcription. | 
| + | - | nl | Circulation 115(10):1180-3 (2007) Giordano FJ |
| 75 | 2006 | Large animal models and gene therapy. | 
| + | - | nl | Eur J Hum Genet 14(3):266-72 (2006) |
| 76 | 2001 | The promise and potential hazards of adenovirus gene therapy. | 
| + | - | nl | Gut 48(5):733-6 (2001) |
| 77 | 1997 | Gene delivery to the epidermis. | 
| + | - | nl | Hum Mol Genet 6(10):1761-7 (1997) |
| 78 | 1993 | Transgenesis in nonmurine species. | 
| + | - | nl | Hypertension 22(4):630-3 (1993) |
| 79 | 2000 | Renal transfer of genetically engineered cells. | 
| + | - | nl | J Am Soc Nephrol 11 Suppl 16(-):S154-8 (2000) |
| 80 | 2000 | Critical aspects of viral vectors for gene transfer into the kidney. | 
| + | - | nl | J Am Soc Nephrol 11 Suppl 16(-):S149-53 (2000) |
| 81 | 2002 | Gene electrotransfer: potential for gene therapy of renal diseases. | 
| + | - | nl | Kidney Int 61(1 Suppl):S37-41 (2002) |
| 82 | 2002 | New generation adenoviral vectors improve gene transfer by coxsackie and adenoviral receptor-independent cell entry. | 
| + | - | nl | Kidney Int 61(1 Suppl):S24-31 (2002) |
| 83 | 2002 | Recent advances in recombinant adeno-associated virus vector production. | 
| + | - | nl | Kidney Int 61(1 Suppl):S9-15 (2002) |
| 84 | 2002 | Herpes simplex virus as a model vector system for gene therapy in renal disease. | 
| + | - | nl | Kidney Int 61(1 Suppl):S3-8 (2002) |
| 85 | 1998 | Strategies of gene transfer to the kidney. | 
| + | - | nl | Kidney Int 53(2):264-72 (1998) |
| 86 | 2005 | Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy. | 
| + | - | nl | NeuroRx 2(1):129-38 (2005) |
| 87 | 2006 | Modeling chromosomes in mouse to explore the function of genes, genomic disorders, and chromosomal organization. | 
| + | - | nl | PLoS Genet 2(7):e86 (2006) |
| 88 | 2009 | Well-defined cationic shell crosslinked nanoparticles for efficient delivery of DNA or peptide nucleic acids. | 
| + | - | nl | Proc Am Thorac Soc 6(5):450-7 (2009) |
| 89 | 2000 | Size does matter: overcoming the adeno-associated virus packaging limit. | 
| + | - | nl | Respir Res 1(1):16-8 (2000) |
| 90 | 2006 | Gene therapy of liver cancer. | 
| + | - | nl | World J Gastroenterol 12(38):6085-97 (2006) |
| 91 | 2006 | Ocular gene therapy: a review of nonviral strategies. | 
| + | - | nl | Mol Vis 12(-):1334-47 (2006) |
| 92 | 2004 | Lentiviral vectors. | 
| + | - | nl | J Biomed Sci 11(4):439-49 (2004) |
| 93 | 2000 | Adeno-associated virus-based vectors in gene therapy. | 
| + | - | nl | J Biomed Sci 7(4):279-91 (2000) |
| 94 | 2007 | Combating oncogene activation associated with retrovirus-mediated gene therapy of X-linked severe combined immunodeficiency. | 
| + | - | nl | Braz J Med Biol Res 40(5):601-13 (2007) |
| 95 | 1998 | Gene therapy: a primer for radiologists. | 
| + | - | nl | Radiographics 18(6):1343-72 (1998) |
| 96 | 1998 | Vascular gene therapy. | 
| + | - | nl | Radiographics 18(6):1373-94 (1998) |
| 97 | 2003 | Imaging of vascular gene therapy. | 
| + | - | nl | Radiology 228(1):36-49 (2003) |
| 98 | 2008 | Physical approaches for nucleic acid delivery to liver. | 
| + | - | nl | AAPS J 10(4):589-95 (2008) |
| 99 | 2007 | Vectors for airway gene delivery. | 
| + | - | nl | AAPS J 9(1):E11-7 (2007) |
| 100 | 2007 | Peptide-guided gene delivery. | 
| + | - | nl | AAPS J 9(1):E18-29 (2007) |
| 101 | 2009 | Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus. | 
| + | - | nl | AAPS J 11(1):65-77 (2009) |
| 102 | 2005 | DNA-based therapeutics and DNA delivery systems: a comprehensive review. | 
| + | - | nl | AAPS J 7(1):E61-77 (2005) |
| 103 | 2009 | Nonviral gene delivery: principle, limitations, and recent progress. | 
| + | - | nl | AAPS J 11(4):671-81 (2009) |
| 104 | 2009 | Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation. | 
| + | - | nl | AAPS J 11(1):23-30 (2009) |
| 105 | 2010 | Nonviral gene transfer as a tool for studying transcription regulation of xenobiotic metabolizing enzymes. | 
| + | - | nl | Adv Drug Deliv Rev 62(13):1250-6 (2010) |
| 106 | 2009 | Lentiviral delivery of short hairpin RNAs. | 
| + | - | nl | Adv Drug Deliv Rev 61(9):732-45 (2009) |
| 107 | 2009 | Antioxidant enzyme gene transfer for ischemic diseases. | 
| + | - | nl | Adv Drug Deliv Rev 61(4):351-63 (2009) |
| 108 | 2009 | Transcriptional targeting of tumor endothelial cells for gene therapy. | 
| + | - | nl | Adv Drug Deliv Rev 61(7-8):542-53 (2009) |
| 109 | 2008 | Multilayered polyelectrolyte assemblies as platforms for the delivery of DNA and other nucleic acid-based therapeutics. | 
| + | - | nl | Adv Drug Deliv Rev 60(9):979-99 (2008) |
| 110 | 2003 | Fratricidal retroviruses: a new twist in gene therapy. | 
| + | - | nl | Cancer Biol Ther 2(1):100-2 (2003) Rabson AB |
| 111 | 2007 | Radiation to control transgene expression in tumors. | 
| + | - | nl | Cancer Biol Ther 6(7):1005-12 (2007) |
| 112 | 2005 | Achieving hypoxia-inducible gene expression in tumors. | 
| + | - | nl | Cancer Biol Ther 4(4):359-64 (2005) |
| 113 | 2003 | Gene therapy for psychiatric disorders. | 
| + | - | nl | Am J Psychiatry 160(2):208-20 (2003) |
| 114 | 2010 | Lentiviral vectors in gene therapy: their current status and future potential. | 
| + | - | nl | Arch Immunol Ther Exp (Warsz) 58(2):107-19 (2010) |
| 115 | 2010 | The role of liver sinusoidal cells in hepatocyte-directed gene transfer. | 
| + | - | nl | Am J Pathol 176(1):14-21 (2010) |
| 116 | 2003 | Primer on medical genomics. Part X: Gene therapy. | 
| + | - | nl | Mayo Clin Proc 78(11):1370-83 (2003) |
| 117 | 2005 | Pulsed high-intensity focused ultrasound enhances systemic administration of naked DNA in squamous cell carcinoma model: initial experience. | 
| + | - | nl | Radiology 235(2):541-6 (2005) |
| 118 | 2006 | Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo. | 
| + | - | nl | J Biomed Biotechnol 2006(4):71659 (2006) |
| 119 | 2010 | Exon skipping with morpholino oligomers: new treatment option for cardiomyopathy in Duchenne muscular dystrophy? | 
| + | - | nl | Cardiovasc Res 85(3):409-10 (2010) Bauer R |
| 120 | 2009 | Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells. | 
| + | - | nl | Blood 114(8):1461-8 (2009) |
| 121 | 2010 | Gene therapy for vision loss -- recent developments. | 
| + | - | nl | Discov Med 10(54):425-33 (2010) |
| 122 | 2009 | Viral vectors: from virology to transgene expression. | 
| + | - | nl | Br J Pharmacol 157(2):153-65 (2009) |
| 123 | 2009 | Physical methods of nucleic acid transfer: general concepts and applications. | 
| + | - | nl | Br J Pharmacol 157(2):207-19 (2009) Villemejane J |
| 124 | 2003 | Targeted genetic repair: an emerging approach to genetic therapy. | 
| + | - | nl | J Clin Invest 112(3):310-1 (2003) |
| 125 | 2003 | Ribozyme-mediated revision of RNA and DNA. | 
| + | - | nl | J Clin Invest 112(3):312-8 (2003) Long MB |
| 126 | 2003 | Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing. | 
| + | - | nl | J Clin Invest 112(4):474-80 (2003) |
| 127 | 2003 | The potential for gene repair via triple helix formation. | 
| + | - | nl | J Clin Invest 112(4):487-94 (2003) |
| 128 | 2007 | Meganuclease and transposon mediated transgenesis in medaka. | 
| + | - | nl | Genome Biol 8 Suppl 1(-):S10 (2007) |
| 129 | 2007 | Manipulating the Xenopus genome with transposable elements. | 
| + | - | nl | Genome Biol 8 Suppl 1(-):S11 (2007) |
| 130 | 2007 | Predicting preferential DNA vector insertion sites: implications for functional genomics and gene therapy. | 
| + | - | nl | Genome Biol 8 Suppl 1(-):S12 (2007) |
| 131 | 2007 | Pigs taking wing with transposons and recombinases. | 
| + | - | nl | Genome Biol 8 Suppl 1(-):S13 (2007) |
| 132 | 2004 | Lentiviral transgene vectors. | 
| + | - | nl | EMBO Rep 5(1):28-9 (2004) |
| 133 | 2007 | Toward reprogramming bacteria with small molecules and RNA. | 
| + | - | nl | Curr Opin Chem Biol 11(6):612-9 (2007) |
| 134 | 2011 | Gammaretroviral vectors: biology, technology and application. | 
| + | - | nl | Viruses 3(6):677-713 (2011) |
| 135 | 2011 | The inside out of lentiviral vectors. | 
| + | - | nl | Viruses 3(2):132-59 (2011) |
| 136 | 2011 | Retroviral vectors: post entry events and genomic alterations. | 
| + | - | nl | Viruses 3(5):429-55 (2011) |
| 137 | 2010 | Serotype chimeric human adenoviruses for cancer gene therapy. | 
| + | - | nl | Viruses 2(10):2196-212 (2010) |
| 138 | 2010 | Development of viral vectors for use in cardiovascular gene therapy. | 
| + | - | nl | Viruses 2(2):334-71 (2010) |
| 139 | 2010 | PEGylated Adenoviruses: From Mice to Monkeys. | 
| + | - | nl | Viruses 2(2):468-502 (2010) |
| 140 | 2008 | Gene therapy using adeno-associated virus vectors. | 
| + | - | nl | Clin Microbiol Rev 21(4):583-93 (2008) |
| 141 | 2003 | Harnessing apoptosis for improved anticancer gene therapy. | 
| + | - | nl | Cancer Res 63(24):8563-72 (2003) |
| 142 | 2004 | Gene therapy in clinical medicine. | 
| + | - | nl | Postgrad Med J 80(948):560-70 (2004) |
| 143 | 2004 | Lentiviral vectors for the central nervous system. | 
| + | - | nl | MedGenMed 6(3):17 (2004) |
| 144 | 2010 | Transfection techniques for neuronal cells. | 
| + | - | nl | J Neurosci 30(18):6171-7 (2010) |
| 145 | 2011 | Application of magnetic nanoparticles to gene delivery. | 
| + | - | nl | Int J Mol Sci 12(6):3705-22 (2011) |
| 146 | 2008 | Recent developments in peptide-based nucleic acid delivery. | 
| + | - | nl | Int J Mol Sci 9(7):1276-320 (2008) |
| 147 | 2009 | RNAi nanoparticles in the service of personalized medicine. | 
| + | - | nl | Nanomedicine (Lond) 4(8):853-5 (2009) |
| 148 | 2010 | Cellular endocytosis and gene delivery. | 
| + | - | nl | Mol Med 16(5-6):222-9 (2010) |